Nuveen Quality Municipal Income Fund (NAD) Drawdown History
50 recorded drawdown events with recovery analysis
Price
$11.44
All-Time High
$12.69
Current Drawdown
-9.8%
Severity Score
3.3
Zone
Elevated
Drawdown Distribution
How NAD's 50 recorded drawdowns break down by severity:
48
< 5%
0
5-10%
1
10-20%
1
20-30%
0
30%+
Recovery Patterns
When NAD drops 10% or more from its high, it has happened 2 times with an average duration of 628 days and an average maximum drop of -20.4%.
Drops of 20% or more have occurred 1 times, lasting an average of 253 days with an average depth of -25.4%.
All Drawdown Events
Showing 2 events with drops of 5% or more, sorted by depth.
| # | Start Date | End Date | Max Drop | Duration | Start Price | Low Price |
|---|---|---|---|---|---|---|
| 1 | 2020-03-09 | 2020-11-16 | -25.4% | 253 days | $10.97 | $8.19 |
| 2 | 2016-08-15 | 2019-05-13 | -15.4% | 1002 days | $9.57 | $8.10 |
48 minor events (under 5% drop) not shown.
Frequently Asked Questions
What is NAD's biggest all-time drawdown?
Nuveen Quality Municipal Income Fund's deepest recorded drawdown was -25.4%, which occurred from 2020-03-09 to 2020-11-16 and lasted 253 days. The stock dropped from $10.97 to a low of $8.19.
How long does it take NAD to recover from a drawdown?
When NAD drops 10% or more from its high, it has historically recovered within an average of 628 days. This is based on 2 comparable events in the tracked history.
Is NAD at an all-time high?
No, Nuveen Quality Municipal Income Fund is currently trading at $11.44, which is -9.8% below its all-time high of $12.69. The current Drawdown Severity Score is 3.3 (Elevated).
How many drawdown events has NAD experienced?
Nuveen Quality Municipal Income Fund has experienced 50 tracked drawdown events. Of these, 2 were drops of 5% or more. The average maximum drawdown across all events is -1.9%.
Track NAD's Severity Score
Set custom alerts for Nuveen Quality Municipal Income Fund and get notified when it crosses into new severity zones.
Get Started FreeDisclaimer: DrawdownAlerts provides historical data analysis, not financial advice. Past performance does not guarantee future results. Severity scores are analytical tools, not buy/sell signals. Always do your own research before making investment decisions.